Advanced Search

 

Study ID Status Title Patient Level Data
AVD111179 Completed A 52 Week Randomized, Double-Blind, Multicenter, Mechanistic Study with a 24 Week Open-Label Follow-Up to Evaluate the Effect of AVANDIA TM on Bone in Postmenopausal Women with Type 2 Diabetes Mellitus Study Listed on ClinicalStudyDataRequest.com
AVM100264 Completed A randomised, multi-centre, phase IV, double-blind, parallel group study comparing the effects of 52 weeks administration of AVANDAMET and metformin plus sulphonylurea on change in HbA1c from baseline in overweight type 2 diabetics poorly controlled on metformin.
AVO-001/2003 Completed Observational post marketing surveillance study of the safety and efficacy of dutasteride (Avodart®) in patients with benign prostatic hyperplasia
AVO105948 Completed A Randomized, Double-Blind, Placebo-Controlled Trial Assessing the Efficacy and Safety of Dutasteride in Extending the Time to Progression of Low-Risk, Localized Prostate Cancer in Men who are Candidates for or Undergoing Expectant Management Study Listed on ClinicalStudyDataRequest.com
AVO108943 Completed A Randomized Double-Blind Parallel Group Study Comparing Casodex (or generic equivalent) 50mg plus Placebo to Casodex (or generic equivalent) 50mg plus dutasteride 3.5mg Administered for 18 months to Men with Prostate Cancer Who Have Failed First-Line Androgen Deprivation Therapy (Assessed by Rising PSA) Followed by a Two-Year Extension Phase Study Listed on ClinicalStudyDataRequest.com
AVS101946 Completed A 16 week randomized, double-blind, parallel group study to evaluate the efficacy and safety of a new medication (GSK523338) to lower LDL-c and HbA1c in subjects with type 2 diabetes mellitus Study Listed on ClinicalStudyDataRequest.com
AVT105913 Completed A randomized, parallel group, double-blind, multi-center study comparing the efficacy and safety of AVANDAMET and metformin after 80 weeks of treatment. Study Listed on ClinicalStudyDataRequest.com
AXO110461 Completed A single-blinded, randomized, placebo-controlled, staggered-parallel, escalating single dose study to investigate the safety, tolerability, pharmacokinetics and pharmacodynamics of orally administered SB756050 in healthy volunteers and in subjects with Type 2 Diabetes Mellitus Study Listed on ClinicalStudyDataRequest.com
AXR107453 Completed An Open-Label, Randomized, two-Period Crossover Study to Demonstrate the Bioequivalence of a Tablet Formulation of Rosiglitazone XR (BRL-049653) 8mg manufactured at two different sites in healthy volunteers in fasting conditions
AZ3100603 Completed A phase IIa/b double-blind, randomised, placebo-controlled, linear trend design dose-ranging study to investigate the effects of 24 weeks of monotherapy with SB-742457 on cognition in subjects with mild to moderate Alzheimer's disease
AZ3106242 Completed A Double-Blind, Randomised, Placebo-Controlled, Parallel Group Study to Investigate the Effects of SB-742457, Donepezil and Placebo on Cognition in Subjects with Mild to Moderate Alzheimer’s Disease
AZ3110865 Completed Study AZ3110865, a study comparing SB-742457 or donepezil versus placebo in subjects with mild-to-moderate Alzheimer’s disease
AZ3110866 Completed Study AZ3110866, a fixed dose study of SB-742457 versus placebo when added to existing donepezil treatment in subjects with mild-to-moderate Alzheimer’s disease
AZA30002 Completed An open, non-controlled study to investigate the safety and efficacy of 12 to 96 weeks of treatment with telmisartan when administered to patients with hypertension.
AZA30003 Completed A prospective double-blind, randomised, placebo-controlled, 3 week crossover study to investigate the effects of telmisartan 40mg on arterial compliance and endothelial function in type 2 diabetes subjects with essential hypertension.
AZA30004 Completed A prospective, double-blind, randomised, placebo-controlled, 3 week cross-over study to investigate the effects of telmisartan on pulse wave velocity and arterial compliance in subjects with isolated systolic hypertension.
AZA30005 Completed A prospective, randomised, open-label, blinded endpoint (PROBE), parallel group study comparing a one-step response based titration regimen of 12 weeks duration of telmisartan with enalapril in patients with essential hypertension.
AZA30006 Completed A prospective, randomized, double-blind, parallel group study to compare the adjunctive effect of telmisartan with existing antihypertensive therapy in patients with essential hypertension that is uncontrolled on current therapy.
AZA30012 Completed An open label randomized study of efficacy and safety of telmisartan administered during 12 weeks in combination and as sequential single therapy (TEAM study).
AZA30013 Completed Comparison, with self measurements of blood pressure, of residual efficacy of telmisartan and perindopril in mild to moderate essential hypertension (EVERESTE study).
AZA30015 Completed P.R.O.B.E. (Prospective, Randomized, Open-label, Blinded Endpoint) multicentre, parallel-group study to evaluate the efficacy of telmisartan 40/80 mg vs losartan 50/100 mg in patients with mild/moderate hypertension
AZA30016 Completed P.R.O.B.E. (Prospective, Randomized, Open label, Blinded Endpoint) multicentre, parallel group study to evaluate the efficacy of telmisartan 40/80 mg vs lisinopril 10/20 mg in the reduction of progressive renal impairment in hypertensive subjects with type 2 diabetes.
AZA30020 Completed Acute effects of the Angiotensin 1 receptor blockade, telmisartan 80 mg, on the nitric oxide flow-mediated vasodilation of radial artery, in healthy volunteers
AZA40052; AZA40053 Completed Telmisartan Therapy for Hypertension in a Primary-Care Setting: A Canadian Observational Study
AZL10001 Completed An Evaluation of the Bioequivalence of a Combined Formulated Tablet (300/150/300mg abacavir/lamivudine/zidovudine) Compared to ZIAGEN (abacavir) 300mg tablet, EPIVIR (lamivudine) 150mg tablet, and RETROVIR (zidovudine) 300mg tablet Administered Concurrently and the Effect of Food on Absorption i ...

 

 

For more information on this register please email GSKClinicalSupportHD@gsk.com

GSK-sponsored clinical studies are those for which GSK is ultimately responsible for all aspects of the study even if some or all of these activities are transferred to another party.
GSK-sponsored clinical trials are those for which GSK is ultimately responsible for all aspects of the study even if some or all of these activities are transferred to another party.

ClinicalTrial.gov is a database that provides summary protocol information for ongoing clinical trials.

IFPMA.org is a search portal provided by the International Federation of Pharamceutical Manufacturers & Associations (IFPMA).

This portal provides a single entry point to search for industry sponsored clinical trials which are on existing registers and databases.

EU Clinical Trials Register is a database of all clinical trials commencing in the European Community from 1 May 2004 onwards. It has been established in accordance with Directive 2001/20/EC.